Index
1 Market Overview of Antibiotics Active Pharmaceutical Ingredient
1.1 Antibiotics Active Pharmaceutical Ingredient Market Overview
1.1.1 Antibiotics Active Pharmaceutical Ingredient Product Scope
1.1.2 Antibiotics Active Pharmaceutical Ingredient Market Status and Outlook
1.2 Global Antibiotics Active Pharmaceutical Ingredient Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2018-2029)
1.4 Global Antibiotics Active Pharmaceutical Ingredient Historic Market Size by Region (2018-2023)
1.5 Global Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Antibiotics Active Pharmaceutical Ingredient Market Size (2018-2029)
1.6.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size (2018-2029)
1.6.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size (2018-2029)
1.6.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size (2018-2029)
1.6.4 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size (2018-2029)
1.6.5 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size (2018-2029)
2 Antibiotics Active Pharmaceutical Ingredient Market by Type
2.1 Introduction
2.1.1 Penicillin Antibiotics
2.1.2 Cephalosporins
2.1.3 Carbapenem Antibiotics
2.2 Global Antibiotics Active Pharmaceutical Ingredient Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Antibiotics Active Pharmaceutical Ingredient Historic Market Size by Type (2018-2023)
2.2.2 Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Antibiotics Active Pharmaceutical Ingredient Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Antibiotics Active Pharmaceutical Ingredient Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Antibiotics Active Pharmaceutical Ingredient Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient Revenue Breakdown by Type (2018-2029)
3 Antibiotics Active Pharmaceutical Ingredient Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Companies
3.1.2 Contract Manufacturing Organizations (CMOs)
3.1.3 Contract Development & Manufacturing Organizations (CDMOs)
3.2 Global Antibiotics Active Pharmaceutical Ingredient Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Antibiotics Active Pharmaceutical Ingredient Historic Market Size by Application (2018-2023)
3.2.2 Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Antibiotics Active Pharmaceutical Ingredient Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Antibiotics Active Pharmaceutical Ingredient Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Antibiotics Active Pharmaceutical Ingredient Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient Revenue Breakdown by Application (2018-2029)
4 Antibiotics Active Pharmaceutical Ingredient Competition Analysis by Players
4.1 Global Antibiotics Active Pharmaceutical Ingredient Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibiotics Active Pharmaceutical Ingredient as of 2022)
4.3 Date of Key Players Enter into Antibiotics Active Pharmaceutical Ingredient Market
4.4 Global Top Players Antibiotics Active Pharmaceutical Ingredient Headquarters and Area Served
4.5 Key Players Antibiotics Active Pharmaceutical Ingredient Product Solution and Service
4.6 Competitive Status
4.6.1 Antibiotics Active Pharmaceutical Ingredient Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sandoz International
5.1.1 Sandoz International Profile
5.1.2 Sandoz International Main Business
5.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.1.4 Sandoz International Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.1.5 Sandoz International Recent Developments
5.2 Centrient Pharmaceuticals
5.2.1 Centrient Pharmaceuticals Profile
5.2.2 Centrient Pharmaceuticals Main Business
5.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.2.4 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.2.5 Centrient Pharmaceuticals Recent Developments
5.3 CordenPharma International
5.3.1 CordenPharma International Profile
5.3.2 CordenPharma International Main Business
5.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.3.4 CordenPharma International Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.3.5 ACS DOBFAR Recent Developments
5.4 ACS DOBFAR
5.4.1 ACS DOBFAR Profile
5.4.2 ACS DOBFAR Main Business
5.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.4.4 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.4.5 ACS DOBFAR Recent Developments
5.5 Nanjing Dorra Pharmaceutical Technology
5.5.1 Nanjing Dorra Pharmaceutical Technology Profile
5.5.2 Nanjing Dorra Pharmaceutical Technology Main Business
5.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.5.4 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.5.5 Nanjing Dorra Pharmaceutical Technology Recent Developments
5.6 DAEWOONG PHARMACEUTICAL
5.6.1 DAEWOONG PHARMACEUTICAL Profile
5.6.2 DAEWOONG PHARMACEUTICAL Main Business
5.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.6.4 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.6.5 DAEWOONG PHARMACEUTICAL Recent Developments
5.7 Parabolic Drugs
5.7.1 Parabolic Drugs Profile
5.7.2 Parabolic Drugs Main Business
5.7.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.7.4 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.7.5 Parabolic Drugs Recent Developments
5.8 Penam Laboratories
5.8.1 Penam Laboratories Profile
5.8.2 Penam Laboratories Main Business
5.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.8.4 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.8.5 Penam Laboratories Recent Developments
5.9 ASIATIC DRUGS & PHARMACEUTICALS
5.9.1 ASIATIC DRUGS & PHARMACEUTICALS Profile
5.9.2 ASIATIC DRUGS & PHARMACEUTICALS Main Business
5.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.9.4 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.9.5 ASIATIC DRUGS & PHARMACEUTICALS Recent Developments
5.10 Fresenius Kabi
5.10.1 Fresenius Kabi Profile
5.10.2 Fresenius Kabi Main Business
5.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.10.4 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.10.5 Fresenius Kabi Recent Developments
5.11 The United Laboratories International Holdings
5.11.1 The United Laboratories International Holdings Profile
5.11.2 The United Laboratories International Holdings Main Business
5.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.11.4 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.11.5 The United Laboratories International Holdings Recent Developments
5.12 Aurobindo Pharma Limited
5.12.1 Aurobindo Pharma Limited Profile
5.12.2 Aurobindo Pharma Limited Main Business
5.12.3 Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.12.4 Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.12.5 Aurobindo Pharma Limited Recent Developments
5.13 Unimark Remedies
5.13.1 Unimark Remedies Profile
5.13.2 Unimark Remedies Main Business
5.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.13.4 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.13.5 Unimark Remedies Recent Developments
5.14 Savior Lifetec
5.14.1 Savior Lifetec Profile
5.14.2 Savior Lifetec Main Business
5.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Products, Services and Solutions
5.14.4 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Revenue (US$ Million) & (2018-2023)
5.14.5 Savior Lifetec Recent Developments
6 North America
6.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antibiotics Active Pharmaceutical Ingredient Market Dynamics
11.1 Antibiotics Active Pharmaceutical Ingredient Industry Trends
11.2 Antibiotics Active Pharmaceutical Ingredient Market Drivers
11.3 Antibiotics Active Pharmaceutical Ingredient Market Challenges
11.4 Antibiotics Active Pharmaceutical Ingredient Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List